[paula_w]

On May 27, the National Institute of Neurological Diseases and Stroke (NINDS) announced the halt of a large clinical trial conducted by the Parkinson Study Group (PSG) on the potential beneficial effects of the dietary supplement coenzyme Q10 (CoQ10) on reducing the progression of early Parkinson’s disease (PD).

Their reason: a mid-study analysis suggested that there is no improvement in the CoQ10-treated individuals in comparison to those receiving placebo (empty tablet) treatment and that continuing the program would have a very low likelihood of demonstrating any benefit from coenzyme Q10 usage in delaying the progression of early PD.

The PDF statement, with links to NINDS and PSG can be found here: http://www.pdf.org/en/science_news/release/pr_1306807909.

[aftermathman]

already been blown out of the water some years ago.

Come on Neil, keep up with the failures.

Neil.

P.S. how you doing Paula, I hope things are as good as can be.

[paula_w]

and i wonder if i should mention it neil, but how much was it? total federal dollars...can't stifle the curiousity...

hope you are well.

[johnt]

Is it possible to get hold of the raw data?

John

[paula_w]

we have had difficulty in the past with any data but don't know the goings on just yet. maybe they've moved forward to sharing.